GCM

GCM is a private, private-equity-backed outsourced manufacturer of high-precision components and assemblies serving medical technology OEMs, with additional exposure to aerospace and industrial markets. The company provides an integrated manufacturing platform spanning precision machining, sheet metal fabrication, welding and joining, electro-mechanical assembly, new product introduction, supply chain management, and value engineering. In healthcare, GCM primarily supports MedTech applications such as robotic surgery, radiotherapy/oncology treatment, cardiovascular therapy, and diagnostic platforms rather than developing its own therapeutics. Headquartered in Union City, California, GCM operates manufacturing sites in the United States and China and has expanded through acquisition, including the 2025 asset acquisition of Precision Swiss Products. The company is owned through an Avista-managed continuation vehicle following Avista's 2019 acquisition of GCM from May River Capital.